HER2 Support Group Forums - View Single Post

heblaj01 · 05-02-2006, 12:48 PM

Over time I picked up case reports of alternative treatments showing unusual success for various desperate cases .
Since these reports are always anecdotal cases they usually are dismissed by most MD's. Some of them would however say that the first anecdotal successful treatment for a desperate condition is meaningful.
Anyway, when running out of conventional therapies or when unable or unwilling to tolerate them these alternative treatments (if they are at least backed by some valid preclinical testing) may be worth investigating.

1.High dose curcumin (2x4g daily) for multiple myeloma
http://grouppekurosawa.com/blog/2006/03/multiple-myeloma-update.htm
There is a lot of serious research on curcumin for breast & prostate in
particular at the MD Anderson Cancer Center where a clinical trial is
underway.
2. Intravenous Alpha Lipoic Acid/Low Dose Naltrexone for Pancreatic with Liver Mets
http://ict.sagepub.com/cgi/reprint/5/1/83.pdf
Some MD's have prescribed off label use of low dose naltrexone for
various cancers.
3. High dose omega-3 fish oils for lung cancer
http://www.cabnr.unr.edu/cabnr/newsl...nandcancer.pdf
I talked to an MD who himself has been conventionaly treated for lung cancer.
He dismissed the report. I was impressed by the fact that increasing dosing resulted in better efficacy. In clinical trials dose dependant activity is a good marker for effectiveness.
There is a lot of lab studies on EPA/DHA for various cancers including
breast.(For more info search google for papers by W.A. Hardman).
I have a relative with breast cancer who appears to have benefited from lower doses (3-5g) in reducing significantly the size of 3 axillary lymph nodes (to less than 0.5cm from 1.5cm) & the inflamation around the primary tumour whose size has remained unchanged for a year. I feel pretty sure about the nodes, less so about the primary tumour since other factors may have contributed to keep its size stable.
If these observations reflect the activity of the fish oil it would mimic the outcomes of similar treatments with mice.
4. Intravenous high dose vitamin C : three case reports
http://www.cmaj.ca/cgi/content/full/174/7/937
There was recent recognition by NCI of the possible potential of vitamin C.
A clinical trial is underway at McGill University.
I acquainted an 80 year old man who has kept melonema in check for
over 20 years with oral high doses.
5.Pancreatic Cancer /metastatic Liver: Alpha lipoic acid+Naltrexone
http://ict.sagepub.com/cgi/content/abstract/5/1/83
The Long-term Survival of a Patient With Pancreatic Cancer With Metastases to the Liver After Treatment With the Intravenous -Lipoic Acid/Low-Dose Naltrexone Protocol
Burton M. Berkson Integrative Medical Center of New Mexico and New Mexico State University, Las Cruces

Daniel M. Rubin Scottsdale, Arizona, rubin@rubinmedical.com

Arthur J. Berkson

Department of Family Practice, University of Illinois at Chicago, Illinois Masonic Medical Center, and the Department of Family Practice, Advocate Health Center, Chicago, Illinois

The authors describe the long-term survival of a patient with pancreatic cancer without any toxic adverse effects. The treatment regimen includes the intravenous-lipoic acid and low-dose naltrexone (ALA-N) protocol and a healthy lifestyle program. The patient was told by a reputable university oncology center in October 2002 that there was little hope for his survival. Today, January 2006, however, he is back at work, free from symptoms, and without appreciable progression of his malignancy. The integrative protocol described in this article may have the possibility of extending the life of a patient who would be customarily considered to be terminal. The authors believe that life scientists will one day develop a cure for metastatic pancreatic cancer, perhaps via gene therapy or another biological platform. But until such protocols come to market, the ALA-N protocol should be studied and considered, given its lack of toxicity at levels reported. Several other patients are on this treatment protocol and appear to be doing well at this time

I wonder if anyone else has tried one of the above treatments?
Or tried a new version of the artemisinin pills with sodium butyrate?
(see http://www.herbological.com/herblog/?p=61)

05-02-2006, 12:48 PM	#1
heblaj01 Senior Member Join Date: Apr 2006 Posts: 543	Striking (but anecdotal) case reports Over time I picked up case reports of alternative treatments showing unusual success for various desperate cases . Since these reports are always anecdotal cases they usually are dismissed by most MD's. Some of them would however say that the first anecdotal successful treatment for a desperate condition is meaningful. Anyway, when running out of conventional therapies or when unable or unwilling to tolerate them these alternative treatments (if they are at least backed by some valid preclinical testing) may be worth investigating. 1.High dose curcumin (2x4g daily) for multiple myeloma http://grouppekurosawa.com/blog/2006/03/multiple-myeloma-update.htm There is a lot of serious research on curcumin for breast & prostate in particular at the MD Anderson Cancer Center where a clinical trial is underway. 2. Intravenous Alpha Lipoic Acid/Low Dose Naltrexone for Pancreatic with Liver Mets http://ict.sagepub.com/cgi/reprint/5/1/83.pdf Some MD's have prescribed off label use of low dose naltrexone for various cancers. 3. High dose omega-3 fish oils for lung cancer http://www.cabnr.unr.edu/cabnr/newsl...nandcancer.pdf I talked to an MD who himself has been conventionaly treated for lung cancer. He dismissed the report. I was impressed by the fact that increasing dosing resulted in better efficacy. In clinical trials dose dependant activity is a good marker for effectiveness. There is a lot of lab studies on EPA/DHA for various cancers including breast.(For more info search google for papers by W.A. Hardman). I have a relative with breast cancer who appears to have benefited from lower doses (3-5g) in reducing significantly the size of 3 axillary lymph nodes (to less than 0.5cm from 1.5cm) & the inflamation around the primary tumour whose size has remained unchanged for a year. I feel pretty sure about the nodes, less so about the primary tumour since other factors may have contributed to keep its size stable. If these observations reflect the activity of the fish oil it would mimic the outcomes of similar treatments with mice. 4. Intravenous high dose vitamin C : three case reports http://www.cmaj.ca/cgi/content/full/174/7/937 There was recent recognition by NCI of the possible potential of vitamin C. A clinical trial is underway at McGill University. I acquainted an 80 year old man who has kept melonema in check for over 20 years with oral high doses. 5.Pancreatic Cancer /metastatic Liver: Alpha lipoic acid+Naltrexone http://ict.sagepub.com/cgi/content/abstract/5/1/83 The Long-term Survival of a Patient With Pancreatic Cancer With Metastases to the Liver After Treatment With the Intravenous -Lipoic Acid/Low-Dose Naltrexone Protocol Burton M. Berkson Integrative Medical Center of New Mexico and New Mexico State University, Las Cruces Daniel M. Rubin Scottsdale, Arizona, rubin@rubinmedical.com Arthur J. Berkson Department of Family Practice, University of Illinois at Chicago, Illinois Masonic Medical Center, and the Department of Family Practice, Advocate Health Center, Chicago, Illinois The authors describe the long-term survival of a patient with pancreatic cancer without any toxic adverse effects. The treatment regimen includes the intravenous-lipoic acid and low-dose naltrexone (ALA-N) protocol and a healthy lifestyle program. The patient was told by a reputable university oncology center in October 2002 that there was little hope for his survival. Today, January 2006, however, he is back at work, free from symptoms, and without appreciable progression of his malignancy. The integrative protocol described in this article may have the possibility of extending the life of a patient who would be customarily considered to be terminal. The authors believe that life scientists will one day develop a cure for metastatic pancreatic cancer, perhaps via gene therapy or another biological platform. But until such protocols come to market, the ALA-N protocol should be studied and considered, given its lack of toxicity at levels reported. Several other patients are on this treatment protocol and appear to be doing well at this time I wonder if anyone else has tried one of the above treatments? Or tried a new version of the artemisinin pills with sodium butyrate? (see http://www.herbological.com/herblog/?p=61) Last edited by heblaj01; 07-11-2006 at 01:51 PM.. Reason: corruped web address, adding 5th anecdotal treatment Poor Boldfacing.